Literature DB >> 10903720

CpG-DNA-mediated transient lymphadenopathy is associated with a state of Th1 predisposition to antigen-driven responses.

G B Lipford1, T Sparwasser, S Zimmermann, K Heeg, H Wagner.   

Abstract

Infections can influence concurrent and subsequent Th1 vs Th2 immune responses to Ags. Through pattern recognition of foreign unmethylated CpG dinucleotides, the vertebrate innate immune system can sense infectious danger and typically replies with a Th1-polarized adaptive immune response. We examined whether CpG-DNA exposure would influence subsequent responses to infection and soluble Ags. CpG-DNA injection led to local lymphadenopathy characterized by maintenance of cellular composition with some biasing toward elevated dendritic cell composition. Sustained local production of IL-12 and IFN-gamma from dendritic cells and T cells was shown. Prior injection by up to 2 wk with CpG-DNA protected BALB/c mice from Th2 driven lethal leishmaniasis. CpG-DNA injection by up to 5 wk before soluble Ag challenge resulted in the generation of Ag-specific CTL, Th1 recall responses to Ag, and Th1-polarized Ag-specific Abs. Thus, CpG-DNA instigated a local predisposition for intense CTL responses and Th1-polarized immune responses to subsequent infections or Ag challenge. The induction by the innate immune system of a locally contained hypersensitivity could represent a capacitating immune reaction yielding rapid conditioned responses to secondary infections.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10903720     DOI: 10.4049/jimmunol.165.3.1228

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

Review 1.  Immunostimulatory DNA sequences help to eradicate intracellular pathogens.

Authors:  H Wagner; H Häcker; G B Lipford
Journal:  Springer Semin Immunopathol       Date:  2000

2.  Induction of CD8 T-cell-specific systemic and mucosal immunity against herpes simplex virus with CpG-peptide complexes.

Authors:  Malgorzata Gierynska; Uday Kumaraguru; Seong-Kug Eo; Sujin Lee; Arthur Krieg; Barry T Rouse
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

3.  Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides.

Authors:  Arthur M Krieg
Journal:  Curr Oncol Rep       Date:  2004-03       Impact factor: 5.075

4.  Optimized systemic dosing with CpG DNA enhances dendritic cell-mediated rejection of a poorly immunogenic mammary tumor in BALB/c mice.

Authors:  Quan Cai; Lyubov Kublo; Rachel Cumberland; William Gooding; Joseph Baar
Journal:  Clin Transl Sci       Date:  2009-02       Impact factor: 4.689

5.  The 3' CCACCA sequence of tRNAAla(UGC) is the motif that is important in inducing Th1-like immune response, and this motif can be recognized by Toll-like receptor 3.

Authors:  Zhijun Wang; Li Xiang; Junjie Shao; Zhenghong Yuan
Journal:  Clin Vaccine Immunol       Date:  2006-07

6.  Preinfection treatment of resistant mice with CpG oligodeoxynucleotides renders them susceptible to friend retrovirus-induced leukemia.

Authors:  Anke R M Olbrich; Simone Schimmer; Ulf Dittmer
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Intranasal CpG therapy attenuated experimental fungal asthma in a TLR9-dependent and -independent manner.

Authors:  Hemanth Ramaprakash; Cory M Hogaboam
Journal:  Int Arch Allergy Immunol       Date:  2009-12-16       Impact factor: 2.749

8.  CpG-enhanced CD8+ T-cell responses to peptide immunization are severely inhibited by B cells.

Authors:  Michael G Overstreet; Helen Freyberger; Ian A Cockburn; Yun-Chi Chen; Sze-Wah Tse; Fidel Zavala
Journal:  Eur J Immunol       Date:  2010-01       Impact factor: 5.532

9.  Innate immune therapy with a Bacillus Calmette-Guérin cell wall skeleton after radical surgery for non-small cell lung cancer: a case-control study.

Authors:  Ken Kodama; Masahiko Higashiyama; Koji Takami; Kazuyuki Oda; Jiro Okami; Jun Maeda; Takashi Akazawa; Misako Matsumoto; Tsukasa Seya; Mariko Wada; Kumao Toyoshima
Journal:  Surg Today       Date:  2009-03-12       Impact factor: 2.549

10.  Cytotoxic-T-lymphocyte human papillomavirus type 16 E5 peptide with CpG-oligodeoxynucleotide can eliminate tumor growth in C57BL/6 mice.

Authors:  Yi-Fang Chen; Chih-Wei Lin; Yeou-Ping Tsao; Show-Li Chen
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.